| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunohistochemistry - free floating section; human; 1:500; loading ...; fig 3b
- western blot; human; 1:1000; fig 5d
| Stein C, McLendon J, Witmer N, Boudreau R. Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson's disease. Mol Ther Nucleic Acids. 2022;28:1-15 pubmed publisher |
- immunohistochemistry; mouse; 1:1000; loading ...; fig 2a
| Suzuki G, Imura S, Hosokawa M, Katsumata R, Nonaka T, Hisanaga S, et al. α-synuclein strains that cause distinct pathologies differentially inhibit proteasome. elife. 2020;9: pubmed publisher |
- immunocytochemistry; human; 1:10,000
| Kett L, Stiller B, Bernath M, Tasset I, Blesa J, Jackson Lewis V, et al. α-Synuclein-independent histopathological and motor deficits in mice lacking the endolysosomal Parkinsonism protein Atp13a2. J Neurosci. 2015;35:5724-42 pubmed publisher |
- western blot; human; fig 6
| Dettmer U, Newman A, Luth E, Bartels T, Selkoe D. In vivo cross-linking reveals principally oligomeric forms of ?-synuclein and ?-synuclein in neurons and non-neural cells. J Biol Chem. 2013;288:6371-85 pubmed publisher |
| Inoue S, Nishimura K, Gima S, Nakano M, Takata K. CRISPR-Cas9-Edited SNCA Knockout Human Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons and Their Vulnerability to Neurotoxicity. Biol Pharm Bull. 2023;46:517-522 pubmed publisher |
| Siracusa R, Scuto M, Fusco R, Trovato A, Ontario M, Crea R, et al. Anti-inflammatory and Anti-oxidant Activity of Hidrox® in Rotenone-Induced Parkinson's Disease in Mice. Antioxidants (Basel). 2020;9: pubmed publisher |
| Vasquez V, Mitra J, Perry G, Rao K, Hegde M. An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1. J Alzheimers Dis. 2018;66:453-460 pubmed publisher |
| Mackenzie I, Nicholson A, Sarkar M, Messing J, Purice M, Pottier C, et al. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron. 2017;95:808-816.e9 pubmed publisher |
| Brahmachari S, Ge P, Lee S, Kim D, Karuppagounder S, Kumar M, et al. Activation of tyrosine kinase c-Abl contributes to ?-synuclein-induced neurodegeneration. J Clin Invest. 2016;126:2970-88 pubmed publisher |
| Tanji K, Miki Y, Maruyama A, Mori F, Mimura J, Itoh K, et al. The role of NUB1 in α-synuclein degradation in Lewy body disease model mice. Biochem Biophys Res Commun. 2016;470:635-642 pubmed publisher |
| Dansithong W, Paul S, Scoles D, Pulst S, Huynh D. Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening. PLoS ONE. 2015;10:e0136930 pubmed publisher |
| Arawaka S, Fukushima S, Sato H, Sasaki A, Koga K, Koyama S, et al. Zonisamide attenuates ?-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's disease. PLoS ONE. 2014;9:e89076 pubmed publisher |
